Answers are grounded in this paper and cite their sources.
Analysis explores DASH diet impact on mortality in adults with and without chronic kidney disease, suggesting tailored dietary strategies.
The Dietary Approaches to Stop Hypertension (DASH) diet has been associated with reduced cardiovascular risk, but its impact on mortality in individuals with chronic kidney disease (CKD) remains uncertain. We analyzed data from 37,827 adults in the NHANES 1999–2014 cycles (without diabetes). Participants were stratified by CKD status (eGFR < 60 mL/min/1.73 m²) and DASH adherence (above or below median score). Mortality outcomes were assessed via the National Death Index. Multivariable Cox regression models, adjusted for demographics, comorbidities, and diet, were used to evaluate associations with all-cause, cardiovascular (CV), and cancer mortality. High DASH adherence was associated with healthier metabolic profiles and lower blood pressure. Among non-CKD participants, higher DASH scores were linked to significantly lower composite CV or cancer mortality (HR 0.896; 95% CI, 0.806–0.997; p = 0.0431), but not to all-cause, CV, or cancer mortality individually. No significant mortality associations were observed in participants with CKD, and interaction effects between DASH and CKD status were non-significant. Higher intake of dietary fiber, magnesium, and potassium was associated with reduced mortality in the overall and non-CKD populations. However, in CKD participants, high magnesium and potassium intake were paradoxically associated with increased cancer mortality. Greater adherence to the DASH diet is associated with lower CV and cancer-related mortality among individuals without CKD. In CKD patients, the benefits are less clear, and some nutrients may have differential effects. Personalized dietary strategies based on kidney function may be warranted. This study explored whether the DASH diet, known for lowering blood pressure, could reduce the risk of death in people with and without chronic kidney disease (CKD). Researchers analyzed data from 37,827 U.S. adults collected between 1999 and 2014. Participants were grouped by kidney function and how closely they followed the DASH diet. Among those without CKD, higher DASH adherence was linked to lower risk of death from heart disease or cancer. However, in people with CKD, no clear benefit was observed, and higher intakes of magnesium and potassium—normally healthy—were linked to increased cancer risk. This suggests that while the DASH diet may help many people live longer, those with CKD may need a more personalized diet. The findings highlight the importance of adjusting dietary recommendations based on kidney function.
No takes yet. Share an insight, caveat, or question.
Tsai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: